PharmiWeb.com - Global Pharma News & Resources
21-May-2024

Tumor Ablation Market Trends 2024 : Rise in Demand for Minimally Invasive Tumor Ablation Techniques to Surpass  USD 24.7 Billion Market Revenue By 2031

Allied Market Research published a report, titled, Tumor Ablation Market by Technology (Radiofrequency Ablation, Microwave Ablation, Cryo-Ablation, Irreversible Electroporation Ablation, and Others), Treatment (Surgical Ablation, Laparoscopic Ablation, and Percutaneous Ablation), and Application (Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, and Bone Cancer): Global Opportunity Analysis and Industry Forecast, 2023–2032.”. According to the report, the global tumor ablation market was valued at $1.4 Billion in 2022 and is estimated to reach $5.0 Billion by 2032, exhibiting a CAGR of 13.5% from 2022 to 2032.

Request Sample of the Report on Tumor Ablation Market Forecast 2032- https://www.alliedmarketresearch.com/request-sample/17626

Recent Product Development in the Tumor Ablation Market  

In July 2020, Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for transbronchial microwave ablation technology using robotic-assisted bronchoscopy, which is currently under development.

Recent Product Approval in the Tumor Ablation Market  

In July 2020, Integra LifeSciences Holdings Corporation, a leading global medical technology company, announced today that it has received FDA clearance for a specific indication for neurosurgery for its CUSA Clarity. CUSA Clarity can be used safely and effectively in neurosurgery for the resection of tumors ranging from soft to firm consistencies, which include the removal of primary and secondary malignant, and benign brain and spinal tumors, including but not limited to meningiomas and gliomas.

For Procurement Information- https://www.alliedmarketresearch.com/purchase-enquiry/17626

Recent Acquisition in the Tumor Ablation Market 

In October 2021, Bioventus LLC announced the completion of the acquisition of Misonix, Inc., a provider of minimally invasive therapeutic ultrasonic technologies and regenerative medicine that are designed to enhance clinical outcomes.

Recent Partnership in the Tumor Ablation Market  

In May 2023, Angio Dynamics announced that it has formed a new partnership with Minimax Medical for the international distribution of its product portfolio. The partnership will include the distribution of Minimax Medical’s leading Radiofrequency Ablation System for tumors/nodules on an international level.

Key Benefits for Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the tumor ablation market analysis from 2022 to 2032 to identify the prevailing tumor ablation market opportunity.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the tumor ablation market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global tumor ablation market trends, key players, market segments, application areas, and market growth strategies.

Key findings of the study 

  • By technology, the others segment dominated the tumor ablation market trends in 2022.
  • By treatment, the surgical ablation segment was the highest contributor to the market in 2022.
  • By application, the liver cancer segment dominated the market in 2022, and is expected to continue this trend during the forecast period.
  • By region, North America garnered the largest revenue share in 2022. However, Asia-Pacific is expected to grow at the fastest rate during the forecast period.

Leading Market Players:

  • Medtronic Plc.
  • Boston Scientific Corporation
  • Smith And Nephew Plc.
  • Angiodynamics Inc.
  • Healthtronics Inc.
  • Bioventus LLC
  • Johnson And Johnson
  • Conmed Corporation
  • Olympus Corporation
  • Integra Lifesciences Holdings Corporation

 

Comprehensive Healthcare Industry Research Studies:

Hyperpigmentation Treatment Market https://www.alliedmarketresearch.com/hyperpigmentation-treatment-market-A186336

Genetic Testing Market https://www.alliedmarketresearch.com/genetic-testing-market

 

About Allied Market Research:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

 

Contact
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int’l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

Editor Details

  • Company:
    • The Wire Times
Last Updated: 21-May-2024